APO Research
Talk to an analyst

APO RESEARCH · REPORT

Defibrinated Animal Blood

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Defibrinated Animal Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

8 January 2026192 pages

Choose your research edition.

Industry ResearchDefibrinated Animal Blood Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Defibrinated Animal Blood Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Defibrinated Animal Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Defibrinated Animal Blood Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Defibrinated Animal Blood Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Defibrinated Animal Blood market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Defibrinated Animal Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Defibrinated Animal Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Defibrinated Animal Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Defibrinated Animal Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Defibrinated Animal Blood include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher and Serana Europe, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Defibrinated Animal Blood market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Defibrinated Animal Blood and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Defibrinated Animal Blood sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Defibrinated Animal Blood market size, projected growth trends, production technologies, key applications, and end-use industries.

Defibrinated Animal Blood Segment by Company

Thermo Fisher Scientific

TCS Biosciences

BioMérieux

E & O Laboratories Ltd

Southern Biological

Trafalgar Scientific

HemoStat Laboratories

Dutscher

Serana Europe

Innovative Research Inc

Colorado Serum

SSI Diagnostica

SR Group

Szabo-Scandic

Rockland Immunochemicals, Inc.

LABone Scientific Co.Ltd.

Biowest(BioNordic A/S)

Pel-Freez Biologicals

EWC Diagnostics

Kraeber & Co. GmbH

Bio Nutrientes Do Brasil Ltda.

Lampire Biological Laboratories, Inc.

Quad Five(Materials Bio Inc.)

Guangzhou Ruite Biotechnology Co., Ltd.

Obio Technology (Shanghai) Corp., Ltd.

Beijing Solarbio Science & Technology Co.,Ltd.

Nanjing SenBeiJia Biological Technology Co., Ltd.

Changde BKMAM Biotechnology Co. Ltd.

Beijing Baiao Leibo Technology Co., Ltd.

Defibrinated Animal Blood Segment by Type

Bovine

Horse

Rabbit

Sheep

Others

Defibrinated Animal Blood Segment by Application

Biomedicine

Research

Defibrinated Animal Blood Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Defibrinated Animal Blood market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Defibrinated Animal Blood and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Defibrinated Animal Blood.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Defibrinated Animal Blood market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Defibrinated Animal Blood manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Defibrinated Animal Blood in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Defibrinated Animal Blood in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Defibrinated Animal Blood Industry Trends Table 2. Defibrinated Animal Blood Industry Drivers Table 3. Defibrinated Animal Blood Industry Opportunities and Challenges Table 4. Defibrinated Animal Blood Industry Restraints Table 5. Global Defibrinated Animal Blood Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Defibrinated Animal Blood Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Defibrinated Animal Blood Sales by Manufacturers (kL) & (2021-2026) Table 8. Global Defibrinated Animal Blood Sales Market Share by Manufacturers Table 9. Global Defibrinated Animal Blood Average Sales Price (USD/L) of Manufacturers (2021-2026) Table 10. Global Defibrinated Animal Blood Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Defibrinated Animal Blood Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Defibrinated Animal Blood Manufacturers, Product Type & Application Table 13. Global Defibrinated Animal Blood Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Defibrinated Animal Blood by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Bovine Table 17. Major Manufacturers of Horse Table 18. Major Manufacturers of Rabbit Table 19. Major Manufacturers of Sheep Table 20. Major Manufacturers of Others Table 21. Global Defibrinated Animal Blood Sales by Type 2021 VS 2025 VS 2032 (kL) Table 22. Global Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 23. Global Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 24. Global Defibrinated Animal Blood Sales Market Share by Type (2021-2026) Table 25. Global Defibrinated Animal Blood Sales Market Share by Type (2027-2032) Table 26. Global Defibrinated Animal Blood Revenue by Type 2021 VS 2025 VS 2032 (kL) Table 27. Global Defibrinated Animal Blood Revenue by Type (2021-2026) & (kL) Table 28. Global Defibrinated Animal Blood Revenue by Type (2027-2032) & (kL) Table 29. Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2026) Table 30. Global Defibrinated Animal Blood Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Biomedicine Table 32. Major Manufacturers of Research Table 33. Global Defibrinated Animal Blood Sales by Application 2021 VS 2025 VS 2032 (kL) Table 34. Global Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 35. Global Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 36. Global Defibrinated Animal Blood Sales Market Share by Application (2021-2026) Table 37. Global Defibrinated Animal Blood Sales Market Share by Application (2027-2032) Table 38. Global Defibrinated Animal Blood Revenue by Application 2021 VS 2025 VS 2032 (kL) Table 39. Global Defibrinated Animal Blood Revenue by Application (2021-2026) & (kL) Table 40. Global Defibrinated Animal Blood Revenue by Application (2027-2032) & (kL) Table 41. Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2026) Table 42. Global Defibrinated Animal Blood Revenue Market Share by Application (2027-2032) Table 43. Global Defibrinated Animal Blood Sales by Region: 2021 VS 2025 VS 2032 (kL) Table 44. Global Defibrinated Animal Blood Sales by Region (2021-2026) & (kL) Table 45. Global Defibrinated Animal Blood Sales Market Share by Region (2021-2026) Table 46. Global Defibrinated Animal Blood Sales Forecasted by Region (2027-2032) & (kL) Table 47. Global Defibrinated Animal Blood Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 49. North America Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 50. North America Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 51. Europe Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 52. Europe Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 53. Europe Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 54. Asia Pacific Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 55. Asia Pacific Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 56. Asia Pacific Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 57. South America, Middle East and Africa Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kL) Table 58. South America, Middle East and Africa Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 59. South America, Middle East and Africa Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 60. Global Defibrinated Animal Blood Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Defibrinated Animal Blood Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Defibrinated Animal Blood Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Defibrinated Animal Blood Revenue Market Share by Region (2021-2026) Table 64. Global Defibrinated Animal Blood Revenue Market Share by Region (2027-2032) Table 65. Thermo Fisher Scientific Company Information Table 66. Thermo Fisher Scientific Business Overview Table 67. Thermo Fisher Scientific Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Thermo Fisher Scientific Defibrinated Animal Blood Product Portfolio Table 69. Thermo Fisher Scientific Recent Development Table 70. TCS Biosciences Company Information Table 71. TCS Biosciences Business Overview Table 72. TCS Biosciences Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. TCS Biosciences Defibrinated Animal Blood Product Portfolio Table 74. TCS Biosciences Recent Development Table 75. BioMérieux Company Information Table 76. BioMérieux Business Overview Table 77. BioMérieux Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. BioMérieux Defibrinated Animal Blood Product Portfolio Table 79. BioMérieux Recent Development Table 80. E & O Laboratories Ltd Company Information Table 81. E & O Laboratories Ltd Business Overview Table 82. E & O Laboratories Ltd Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. E & O Laboratories Ltd Defibrinated Animal Blood Product Portfolio Table 84. E & O Laboratories Ltd Recent Development Table 85. Southern Biological Company Information Table 86. Southern Biological Business Overview Table 87. Southern Biological Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Southern Biological Defibrinated Animal Blood Product Portfolio Table 89. Southern Biological Recent Development Table 90. Trafalgar Scientific Company Information Table 91. Trafalgar Scientific Business Overview Table 92. Trafalgar Scientific Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Trafalgar Scientific Defibrinated Animal Blood Product Portfolio Table 94. Trafalgar Scientific Recent Development Table 95. HemoStat Laboratories Company Information Table 96. HemoStat Laboratories Business Overview Table 97. HemoStat Laboratories Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. HemoStat Laboratories Defibrinated Animal Blood Product Portfolio Table 99. HemoStat Laboratories Recent Development Table 100. Dutscher Company Information Table 101. Dutscher Business Overview Table 102. Dutscher Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Dutscher Defibrinated Animal Blood Product Portfolio Table 104. Dutscher Recent Development Table 105. Serana Europe Company Information Table 106. Serana Europe Business Overview Table 107. Serana Europe Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Serana Europe Defibrinated Animal Blood Product Portfolio Table 109. Serana Europe Recent Development Table 110. Innovative Research Inc Company Information Table 111. Innovative Research Inc Business Overview Table 112. Innovative Research Inc Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Innovative Research Inc Defibrinated Animal Blood Product Portfolio Table 114. Innovative Research Inc Recent Development Table 115. Colorado Serum Company Information Table 116. Colorado Serum Business Overview Table 117. Colorado Serum Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Colorado Serum Defibrinated Animal Blood Product Portfolio Table 119. Colorado Serum Recent Development Table 120. SSI Diagnostica Company Information Table 121. SSI Diagnostica Business Overview Table 122. SSI Diagnostica Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. SSI Diagnostica Defibrinated Animal Blood Product Portfolio Table 124. SSI Diagnostica Recent Development Table 125. SR Group Company Information Table 126. SR Group Business Overview Table 127. SR Group Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. SR Group Defibrinated Animal Blood Product Portfolio Table 129. SR Group Recent Development Table 130. Szabo-Scandic Company Information Table 131. Szabo-Scandic Business Overview Table 132. Szabo-Scandic Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Szabo-Scandic Defibrinated Animal Blood Product Portfolio Table 134. Szabo-Scandic Recent Development Table 135. Rockland Immunochemicals, Inc. Company Information Table 136. Rockland Immunochemicals, Inc. Business Overview Table 137. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product Portfolio Table 139. Rockland Immunochemicals, Inc. Recent Development Table 140. LABone Scientific Co.Ltd. Company Information Table 141. LABone Scientific Co.Ltd. Business Overview Table 142. LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. LABone Scientific Co.Ltd. Defibrinated Animal Blood Product Portfolio Table 144. LABone Scientific Co.Ltd. Recent Development Table 145. Biowest(BioNordic A/S) Company Information Table 146. Biowest(BioNordic A/S) Business Overview Table 147. Biowest(BioNordic A/S) Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Biowest(BioNordic A/S) Defibrinated Animal Blood Product Portfolio Table 149. Biowest(BioNordic A/S) Recent Development Table 150. Pel-Freez Biologicals Company Information Table 151. Pel-Freez Biologicals Business Overview Table 152. Pel-Freez Biologicals Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Pel-Freez Biologicals Defibrinated Animal Blood Product Portfolio Table 154. Pel-Freez Biologicals Recent Development Table 155. EWC Diagnostics Company Information Table 156. EWC Diagnostics Business Overview Table 157. EWC Diagnostics Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. EWC Diagnostics Defibrinated Animal Blood Product Portfolio Table 159. EWC Diagnostics Recent Development Table 160. Kraeber & Co. GmbH Company Information Table 161. Kraeber & Co. GmbH Business Overview Table 162. Kraeber & Co. GmbH Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Kraeber & Co. GmbH Defibrinated Animal Blood Product Portfolio Table 164. Kraeber & Co. GmbH Recent Development Table 165. Bio Nutrientes Do Brasil Ltda. Company Information Table 166. Bio Nutrientes Do Brasil Ltda. Business Overview Table 167. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product Portfolio Table 169. Bio Nutrientes Do Brasil Ltda. Recent Development Table 170. Lampire Biological Laboratories, Inc. Company Information Table 171. Lampire Biological Laboratories, Inc. Business Overview Table 172. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product Portfolio Table 174. Lampire Biological Laboratories, Inc. Recent Development Table 175. Quad Five(Materials Bio Inc.) Company Information Table 176. Quad Five(Materials Bio Inc.) Business Overview Table 177. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product Portfolio Table 179. Quad Five(Materials Bio Inc.) Recent Development Table 180. Guangzhou Ruite Biotechnology Co., Ltd. Company Information Table 181. Guangzhou Ruite Biotechnology Co., Ltd. Business Overview Table 182. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 183. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 184. Guangzhou Ruite Biotechnology Co., Ltd. Recent Development Table 185. Obio Technology (Shanghai) Corp., Ltd. Company Information Table 186. Obio Technology (Shanghai) Corp., Ltd. Business Overview Table 187. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 188. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product Portfolio Table 189. Obio Technology (Shanghai) Corp., Ltd. Recent Development Table 190. Beijing Solarbio Science & Technology Co.,Ltd. Company Information Table 191. Beijing Solarbio Science & Technology Co.,Ltd. Business Overview Table 192. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 193. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product Portfolio Table 194. Beijing Solarbio Science & Technology Co.,Ltd. Recent Development Table 195. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information Table 196. Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview Table 197. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 198. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 199. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Development Table 200. Changde BKMAM Biotechnology Co. Ltd. Company Information Table 201. Changde BKMAM Biotechnology Co. Ltd. Business Overview Table 202. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 203. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product Portfolio Table 204. Changde BKMAM Biotechnology Co. Ltd. Recent Development Table 205. Beijing Baiao Leibo Technology Co., Ltd. Company Information Table 206. Beijing Baiao Leibo Technology Co., Ltd. Business Overview Table 207. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales (kL), Price (USD/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 208. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 209. Beijing Baiao Leibo Technology Co., Ltd. Recent Development Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Defibrinated Animal Blood Distributors List Table 213. Defibrinated Animal Blood Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Defibrinated Animal Blood Product Image Figure 2. Global Defibrinated Animal Blood Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Defibrinated Animal Blood Market Size (2021-2032) & (US$ Million) Figure 4. Global Defibrinated Animal Blood Sales (2021-2032) & (kL) Figure 5. Global Defibrinated Animal Blood Average Price (USD/L) & (2021-2032) Figure 6. Global Top 5 and 10 Defibrinated Animal Blood Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Bovine Image Figure 9. Horse Image Figure 10. Rabbit Image Figure 11. Sheep Image Figure 12. Others Image Figure 13. Global Defibrinated Animal Blood Sales by Type (2021 VS 2025 VS 2032) & (kL) Figure 14. Global Defibrinated Animal Blood Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Defibrinated Animal Blood Sales Market Share by Type (2021-2032) Figure 16. Global Defibrinated Animal Blood Revenue by Type (2021 VS 2025 VS 2032) & (kL) Figure 17. Global Defibrinated Animal Blood Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2032) Figure 19. Biomedicine Image Figure 20. Research Image Figure 21. Global Defibrinated Animal Blood Sales by Application (2021 VS 2025 VS 2032) & (kL) Figure 22. Global Defibrinated Animal Blood Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Defibrinated Animal Blood Sales Market Share by Application (2021-2032) Figure 24. Global Defibrinated Animal Blood Revenue by Application (2021 VS 2025 VS 2032) & (kL) Figure 25. Global Defibrinated Animal Blood Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2032) Figure 27. North America Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 28. North America Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 29. U.S. Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 30. Canada Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 31. Mexico Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 32. Europe Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 33. Europe Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 34. Germany Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 35. France Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 36. U.K. Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 37. Italy Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 38. Netherlands Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 39. Asia Pacific Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 40. Asia Pacific Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 41. China Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 42. Japan Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 43. South Korea Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 44. Southeast Asia Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 45. India Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 46. Australia Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 47. South America, Middle East and Africa Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 48. South America, Middle East and Africa Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 49. Brazil Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 50. South Africa Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 51. Saudi Arabia Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 52. Turkey Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 53. Argentina Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 54. UAE Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 55. Egypt Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 56. Chile Defibrinated Animal Blood Sales and Growth Rate (2021-2032) & (kL) Figure 57. Global Defibrinated Animal Blood Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Defibrinated Animal Blood Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Figure 60. North America Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Figure 62. Europe Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Defibrinated Animal Blood Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Defibrinated Animal Blood Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine
  • Horse
  • Rabbit
  • Sheep
  • Others
Applications
  • Biomedicine
  • Research
Companies covered
  • Thermo Fisher Scientific
  • TCS Biosciences
  • BioMérieux
  • E & O Laboratories Ltd
  • Southern Biological
  • Trafalgar Scientific
  • HemoStat Laboratories
  • Dutscher
  • Serana Europe
  • Innovative Research Inc
  • Colorado Serum
  • SSI Diagnostica
  • SR Group
  • Szabo-Scandic
  • Rockland Immunochemicals, Inc.
  • LABone Scientific Co.Ltd.
  • Biowest(BioNordic A/S)
  • Pel-Freez Biologicals
  • EWC Diagnostics
  • Kraeber & Co. GmbH
  • Bio Nutrientes Do Brasil Ltda.
  • Lampire Biological Laboratories, Inc.
  • Quad Five(Materials Bio Inc.)
  • Guangzhou Ruite Biotechnology Co., Ltd.
  • Obio Technology (Shanghai) Corp., Ltd.
  • Beijing Solarbio Science & Technology Co.,Ltd.
  • Nanjing SenBeiJia Biological Technology Co., Ltd.
  • Changde BKMAM Biotechnology Co. Ltd.
  • Beijing Baiao Leibo Technology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Defibrinated Animal Blood Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Defibrinated Animal Blood Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Defibrinated Animal Blood Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Defibrinated Animal Blood Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Defibrinated Animal Blood Market Dynamics
  1. 2.1 Defibrinated Animal Blood Industry Trends
  2. 2.2 Defibrinated Animal Blood Industry Drivers
  3. 2.3 Defibrinated Animal Blood Industry Opportunities and Challenges
  4. 2.4 Defibrinated Animal Blood Industry Restraints
3 Defibrinated Animal Blood Market by Manufacturers
  1. 3.1 Global Defibrinated Animal Blood Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Defibrinated Animal Blood Sales by Manufacturers (2021-2026)
  3. 3.3 Global Defibrinated Animal Blood Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Defibrinated Animal Blood Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Defibrinated Animal Blood Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Defibrinated Animal Blood Manufacturers, Product Type & Application
  7. 3.7 Global Defibrinated Animal Blood Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Defibrinated Animal Blood Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Defibrinated Animal Blood Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Defibrinated Animal Blood Tier 1, Tier 2, and Tier 3
4 Defibrinated Animal Blood Market by Type
  1. 4.1 Defibrinated Animal Blood Type Introduction
  2. 4.1.1 Bovine
  3. 4.1.2 Horse
  4. 4.1.3 Rabbit
  5. 4.1.4 Sheep
  6. 4.1.5 Others
  7. 4.2 Global Defibrinated Animal Blood Sales by Type
  8. 4.2.1 Global Defibrinated Animal Blood Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Defibrinated Animal Blood Sales by Type (2021-2032)
  10. 4.2.3 Global Defibrinated Animal Blood Sales Market Share by Type (2021-2032)
  11. 4.3 Global Defibrinated Animal Blood Revenue by Type
  12. 4.3.1 Global Defibrinated Animal Blood Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Defibrinated Animal Blood Revenue by Type (2021-2032)
  14. 4.3.3 Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2032)
5 Defibrinated Animal Blood Market by Application
  1. 5.1 Defibrinated Animal Blood Application Introduction
  2. 5.1.1 Biomedicine
  3. 5.1.2 Research
  4. 5.2 Global Defibrinated Animal Blood Sales by Application
  5. 5.2.1 Global Defibrinated Animal Blood Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Defibrinated Animal Blood Sales by Application (2021-2032)
  7. 5.2.3 Global Defibrinated Animal Blood Sales Market Share by Application (2021-2032)
  8. 5.3 Global Defibrinated Animal Blood Revenue by Application
  9. 5.3.1 Global Defibrinated Animal Blood Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Defibrinated Animal Blood Revenue by Application (2021-2032)
  11. 5.3.3 Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2032)
6 Global Defibrinated Animal Blood Sales by Region
  1. 6.1 Global Defibrinated Animal Blood Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Defibrinated Animal Blood Sales by Region (2021-2032)
  3. 6.2.1 Global Defibrinated Animal Blood Sales by Region (2021-2026)
  4. 6.2.2 Global Defibrinated Animal Blood Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Defibrinated Animal Blood Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Defibrinated Animal Blood Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Defibrinated Animal Blood Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Defibrinated Animal Blood Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Defibrinated Animal Blood Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Defibrinated Animal Blood Revenue by Region
  1. 7.1 Global Defibrinated Animal Blood Revenue by Region
  2. 7.1.1 Global Defibrinated Animal Blood Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Defibrinated Animal Blood Revenue by Region (2021-2026)
  4. 7.1.3 Global Defibrinated Animal Blood Revenue by Region (2027-2032)
  5. 7.1.4 Global Defibrinated Animal Blood Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Defibrinated Animal Blood Revenue (2021-2032)
  8. 7.2.2 North America Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Defibrinated Animal Blood Revenue (2021-2032)
  11. 7.3.2 Europe Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Defibrinated Animal Blood Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Defibrinated Animal Blood Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Defibrinated Animal Blood Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Defibrinated Animal Blood Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 TCS Biosciences
  8. 8.2.1 TCS Biosciences Company Information
  9. 8.2.2 TCS Biosciences Business Overview
  10. 8.2.3 TCS Biosciences Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TCS Biosciences Defibrinated Animal Blood Product Portfolio
  12. 8.2.5 TCS Biosciences Recent Developments
  13. 8.3 BioMérieux
  14. 8.3.1 BioMérieux Company Information
  15. 8.3.2 BioMérieux Business Overview
  16. 8.3.3 BioMérieux Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioMérieux Defibrinated Animal Blood Product Portfolio
  18. 8.3.5 BioMérieux Recent Developments
  19. 8.4 E & O Laboratories Ltd
  20. 8.4.1 E & O Laboratories Ltd Company Information
  21. 8.4.2 E & O Laboratories Ltd Business Overview
  22. 8.4.3 E & O Laboratories Ltd Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 E & O Laboratories Ltd Defibrinated Animal Blood Product Portfolio
  24. 8.4.5 E & O Laboratories Ltd Recent Developments
  25. 8.5 Southern Biological
  26. 8.5.1 Southern Biological Company Information
  27. 8.5.2 Southern Biological Business Overview
  28. 8.5.3 Southern Biological Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Southern Biological Defibrinated Animal Blood Product Portfolio
  30. 8.5.5 Southern Biological Recent Developments
  31. 8.6 Trafalgar Scientific
  32. 8.6.1 Trafalgar Scientific Company Information
  33. 8.6.2 Trafalgar Scientific Business Overview
  34. 8.6.3 Trafalgar Scientific Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Trafalgar Scientific Defibrinated Animal Blood Product Portfolio
  36. 8.6.5 Trafalgar Scientific Recent Developments
  37. 8.7 HemoStat Laboratories
  38. 8.7.1 HemoStat Laboratories Company Information
  39. 8.7.2 HemoStat Laboratories Business Overview
  40. 8.7.3 HemoStat Laboratories Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HemoStat Laboratories Defibrinated Animal Blood Product Portfolio
  42. 8.7.5 HemoStat Laboratories Recent Developments
  43. 8.8 Dutscher
  44. 8.8.1 Dutscher Company Information
  45. 8.8.2 Dutscher Business Overview
  46. 8.8.3 Dutscher Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dutscher Defibrinated Animal Blood Product Portfolio
  48. 8.8.5 Dutscher Recent Developments
  49. 8.9 Serana Europe
  50. 8.9.1 Serana Europe Company Information
  51. 8.9.2 Serana Europe Business Overview
  52. 8.9.3 Serana Europe Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Serana Europe Defibrinated Animal Blood Product Portfolio
  54. 8.9.5 Serana Europe Recent Developments
  55. 8.10 Innovative Research Inc
  56. 8.10.1 Innovative Research Inc Company Information
  57. 8.10.2 Innovative Research Inc Business Overview
  58. 8.10.3 Innovative Research Inc Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Innovative Research Inc Defibrinated Animal Blood Product Portfolio
  60. 8.10.5 Innovative Research Inc Recent Developments
  61. 8.11 Colorado Serum
  62. 8.11.1 Colorado Serum Company Information
  63. 8.11.2 Colorado Serum Business Overview
  64. 8.11.3 Colorado Serum Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Colorado Serum Defibrinated Animal Blood Product Portfolio
  66. 8.11.5 Colorado Serum Recent Developments
  67. 8.12 SSI Diagnostica
  68. 8.12.1 SSI Diagnostica Company Information
  69. 8.12.2 SSI Diagnostica Business Overview
  70. 8.12.3 SSI Diagnostica Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SSI Diagnostica Defibrinated Animal Blood Product Portfolio
  72. 8.12.5 SSI Diagnostica Recent Developments
  73. 8.13 SR Group
  74. 8.13.1 SR Group Company Information
  75. 8.13.2 SR Group Business Overview
  76. 8.13.3 SR Group Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 SR Group Defibrinated Animal Blood Product Portfolio
  78. 8.13.5 SR Group Recent Developments
  79. 8.14 Szabo-Scandic
  80. 8.14.1 Szabo-Scandic Company Information
  81. 8.14.2 Szabo-Scandic Business Overview
  82. 8.14.3 Szabo-Scandic Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Szabo-Scandic Defibrinated Animal Blood Product Portfolio
  84. 8.14.5 Szabo-Scandic Recent Developments
  85. 8.15 Rockland Immunochemicals, Inc.
  86. 8.15.1 Rockland Immunochemicals, Inc. Company Information
  87. 8.15.2 Rockland Immunochemicals, Inc. Business Overview
  88. 8.15.3 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product Portfolio
  90. 8.15.5 Rockland Immunochemicals, Inc. Recent Developments
  91. 8.16 LABone Scientific Co.Ltd.
  92. 8.16.1 LABone Scientific Co.Ltd. Company Information
  93. 8.16.2 LABone Scientific Co.Ltd. Business Overview
  94. 8.16.3 LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 LABone Scientific Co.Ltd. Defibrinated Animal Blood Product Portfolio
  96. 8.16.5 LABone Scientific Co.Ltd. Recent Developments
  97. 8.17 Biowest(BioNordic A/S)
  98. 8.17.1 Biowest(BioNordic A/S) Company Information
  99. 8.17.2 Biowest(BioNordic A/S) Business Overview
  100. 8.17.3 Biowest(BioNordic A/S) Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biowest(BioNordic A/S) Defibrinated Animal Blood Product Portfolio
  102. 8.17.5 Biowest(BioNordic A/S) Recent Developments
  103. 8.18 Pel-Freez Biologicals
  104. 8.18.1 Pel-Freez Biologicals Company Information
  105. 8.18.2 Pel-Freez Biologicals Business Overview
  106. 8.18.3 Pel-Freez Biologicals Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Pel-Freez Biologicals Defibrinated Animal Blood Product Portfolio
  108. 8.18.5 Pel-Freez Biologicals Recent Developments
  109. 8.19 EWC Diagnostics
  110. 8.19.1 EWC Diagnostics Company Information
  111. 8.19.2 EWC Diagnostics Business Overview
  112. 8.19.3 EWC Diagnostics Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 EWC Diagnostics Defibrinated Animal Blood Product Portfolio
  114. 8.19.5 EWC Diagnostics Recent Developments
  115. 8.20 Kraeber & Co. GmbH
  116. 8.20.1 Kraeber & Co. GmbH Company Information
  117. 8.20.2 Kraeber & Co. GmbH Business Overview
  118. 8.20.3 Kraeber & Co. GmbH Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Kraeber & Co. GmbH Defibrinated Animal Blood Product Portfolio
  120. 8.20.5 Kraeber & Co. GmbH Recent Developments
  121. 8.21 Bio Nutrientes Do Brasil Ltda.
  122. 8.21.1 Bio Nutrientes Do Brasil Ltda. Company Information
  123. 8.21.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  124. 8.21.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product Portfolio
  126. 8.21.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
  127. 8.22 Lampire Biological Laboratories, Inc.
  128. 8.22.1 Lampire Biological Laboratories, Inc. Company Information
  129. 8.22.2 Lampire Biological Laboratories, Inc. Business Overview
  130. 8.22.3 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product Portfolio
  132. 8.22.5 Lampire Biological Laboratories, Inc. Recent Developments
  133. 8.23 Quad Five(Materials Bio Inc.)
  134. 8.23.1 Quad Five(Materials Bio Inc.) Company Information
  135. 8.23.2 Quad Five(Materials Bio Inc.) Business Overview
  136. 8.23.3 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product Portfolio
  138. 8.23.5 Quad Five(Materials Bio Inc.) Recent Developments
  139. 8.24 Guangzhou Ruite Biotechnology Co., Ltd.
  140. 8.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
  141. 8.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  142. 8.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  144. 8.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
  145. 8.25 Obio Technology (Shanghai) Corp., Ltd.
  146. 8.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
  147. 8.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  148. 8.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product Portfolio
  150. 8.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
  151. 8.26 Beijing Solarbio Science & Technology Co.,Ltd.
  152. 8.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
  153. 8.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Business Overview
  154. 8.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product Portfolio
  156. 8.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments
  157. 8.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
  158. 8.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
  159. 8.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview
  160. 8.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  162. 8.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments
  163. 8.28 Changde BKMAM Biotechnology Co. Ltd.
  164. 8.28.1 Changde BKMAM Biotechnology Co. Ltd. Company Information
  165. 8.28.2 Changde BKMAM Biotechnology Co. Ltd. Business Overview
  166. 8.28.3 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product Portfolio
  168. 8.28.5 Changde BKMAM Biotechnology Co. Ltd. Recent Developments
  169. 8.29 Beijing Baiao Leibo Technology Co., Ltd.
  170. 8.29.1 Beijing Baiao Leibo Technology Co., Ltd. Company Information
  171. 8.29.2 Beijing Baiao Leibo Technology Co., Ltd. Business Overview
  172. 8.29.3 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales, Price, Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  174. 8.29.5 Beijing Baiao Leibo Technology Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Defibrinated Animal Blood Value Chain Analysis
  2. 9.1.1 Defibrinated Animal Blood Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Defibrinated Animal Blood Production Mode & Process
  6. 9.2 Defibrinated Animal Blood Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Defibrinated Animal Blood Distributors
  9. 9.2.3 Defibrinated Animal Blood Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst